TP53 and neoplasm: While STAT3 demonstrates constitutive activation across numerous malignancies, pharmacological intervention with ginsenoside Rh3 specifically attenuated tyrosine-phosphorylated Stat3 levels while elevating total p53 tumor suppressor expression.